References

Skeletal infections: microbial pathogenesis, immunity and clinical management.

10.1038/s41579-022-00686-0 · 2022 · External reference

Diagnosing Fracture-Related Infection: Current Concepts and Recommendations.

10.1097/bot.0000000000001614 · 2020 · External reference

Clinical Practice Guideline for the Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics.

2021 · External reference

infectious diseases society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults.

10.1093/cid/civ482 · 2015 · External reference

Tuberculosis of the spine: a fresh look at an old disease.

2010 · External reference

Osteomyelitis in long bones.

2020 · External reference

PLGA-based nanoparticles: An overview of biomedical applications.

10.1016/j.jconrel.2012.01.043 · 2012 · External reference

Green synthesis of nanoparticles using plant extracts: A review.

2021 · External reference

Date seed extract mediated green synthesis of nanoparticles: characterization and biomedical applications.

2022 · External reference

Green synthesis of metal nanoparticles using plant extracts and evaluation of their antibacterial properties.

2020 · External reference

Advances in green-synthesized nanoparticles for biomedical applications.

2023 · External reference

Green synthesis and characterization of magnesium oxide nanoparticles by using garlic extract.

10.35950/cbej.v30i131.13357 · 2025 · External reference

Intraosseous delivery of antibiotic-loaded PLGA nanoparticles for osteomyelitis treatment.

2020 · External reference

PLGA-based drug delivery systems for bone tissue engineering: a review.

2022 · External reference

An outline of a classification of palms.

1986 · External reference

Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.

10.1016/j.jconrel.2008.02.012 · 2008 · External reference

FTIR Spectrum and XRD Data 2.

10.5281/zenodo.18208346 · 2026 · External reference

Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier.

10.3390/polym3031377 · 2011 · External reference

Biodegradable polymeric nanoparticles based drug delivery systems.

10.1016/j.colsurfb.2009.09.001 · 2010 · External reference

Preparation and characterization of PLGA nanoparticles loaded with doxorubicin: optimization and biological evaluation.

10.1016/j.msec.2020.111092 · 2020 · External reference

PLGA nanoparticles as drug delivery systems: From preparation to clinical application.

10.22034/nmrj.2020.110741 · 2020 · External reference

Nano based drug delivery systems: recent developments and future prospects.

10.1186/s12951-018-0392-8 · 2018 · External reference

Plant extract mediated green synthesis of nanoparticles for biomedical applications: A review.

10.1016/j.molstruc.2021.130082 · 2021 · External reference

Pseudomonas aeruginosa in healthcare-associated infections: From pathogenesis to treatment strategies.

10.1016/j.jhin.2019.11.001 · 2020 · External reference

Antibacterial efficacy of PLGA nanoparticle-loaded antibiotics against Klebsiella pneumoniae.

10.1016/j.ijpharm.2021.120661 · 2021 · External reference

Antimicrobial activity of PLGA nanoparticles against multidrug-resistant Klebsiella pneumoniae.

10.3389/fmicb.2022.802735 · 2022 · External reference

Nanoparticle-based drug delivery systems: Challenges and opportunities in antimicrobial therapy.

2021 · External reference

PLGA Nanoparticles as Delivery Systems for Antibacterial Agents: A Review.

2020 · External reference

Polymeric Nanoparticles in Antibacterial Therapy: Mechanisms and Applications.

2019 · External reference